mmunotherapy is a cancer treatment that exploits the capacity of the body’s immune system to prevent, control, and remove cancer. Immunotherapy has revolutionized cancer treatment and significantly improved patient outcomes for several tumor types. However, most patients have not benefited from such therapies yet. Within the field of cancer immunotherapy, an expansion of the combination strategy that targets independent cellular pathways that can work synergistically is predicted. Here, we review some consequences of tumor cell death and increased immune system engagement in the modulation of oxidative stress and ubiquitin ligase pathways. We also indicate combinations of cancer immunotherapies and immunomodulatory targets. Additionally, we discuss imaging techniques, which are crucial for monitoring tumor responses during treatment and the immunotherapy side effects. Finally, the major outstanding questions are also presented, and directions for future research are described.

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy / Lauriola, Angela; Davalli, Pierpaola; Marverti, Gaetano; Santi, Spartaco; Caporali, Andrea; D’Arca, Domenico. - In: CANCERS. - ISSN 2072-6694. - 15:11(2023), pp. 3009-3050. [10.3390/cancers15113009]

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy

Davalli, Pierpaola;Marverti, Gaetano;D’Arca, Domenico
2023

Abstract

mmunotherapy is a cancer treatment that exploits the capacity of the body’s immune system to prevent, control, and remove cancer. Immunotherapy has revolutionized cancer treatment and significantly improved patient outcomes for several tumor types. However, most patients have not benefited from such therapies yet. Within the field of cancer immunotherapy, an expansion of the combination strategy that targets independent cellular pathways that can work synergistically is predicted. Here, we review some consequences of tumor cell death and increased immune system engagement in the modulation of oxidative stress and ubiquitin ligase pathways. We also indicate combinations of cancer immunotherapies and immunomodulatory targets. Additionally, we discuss imaging techniques, which are crucial for monitoring tumor responses during treatment and the immunotherapy side effects. Finally, the major outstanding questions are also presented, and directions for future research are described.
2023
15
11
3009
3050
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy / Lauriola, Angela; Davalli, Pierpaola; Marverti, Gaetano; Santi, Spartaco; Caporali, Andrea; D’Arca, Domenico. - In: CANCERS. - ISSN 2072-6694. - 15:11(2023), pp. 3009-3050. [10.3390/cancers15113009]
Lauriola, Angela; Davalli, Pierpaola; Marverti, Gaetano; Santi, Spartaco; Caporali, Andrea; D’Arca, Domenico
File in questo prodotto:
File Dimensione Formato  
cancers-15-03009-v3.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 3.91 MB
Formato Adobe PDF
3.91 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1306112
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact